Education
About Us
Working with TipRanks
Follow Us
Diagnos Inc (TSE:ADK)
:ADK
ADK Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.18 - C$0.43
Previous CloseN/A
Volume270.50K
Average Volume (3M)208.53K
Market Cap
C$22.41M
Enterprise ValueC$25.39M
Total Cash (Recent Filing)C$3.24M
Total Debt (Recent Filing)C$3.07M
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding101,862,976
10 Day Avg. Volume347,079
30 Day Avg. Volume208,528
Financial Highlights & Ratios
PEG Ratio1.01
Price to Book (P/B)93.95
Price to Sales (P/S)0.00
P/FCF Ratio-6.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Diagnos News
PremiumCompany Announcements
Diagnos Strengthens US Market Position with New Advisory Board Member
PremiumCompany Announcements
Diagnos Inc. Strengthens US Market Strategy with New Advisory Board Member
PremiumCompany Announcements
DIAGNOS Engages Allele Capital for Strategic Advisory
PremiumCompany Announcements
Diagnos Inc. Extends Convertible Debentures Maturity Date
PremiumCompany Announcements
DIAGNOS Achieves Cybersecurity Milestone for CARA System
PremiumCompany Announcements
Diagnos Inc. Announces Amendment to Convertible DebenturesOptions Prices
Currently, No data available
---
Ownership Overview
2.50% Insiders
―
Mutual Funds
0.29% Other Institutional Investors
97.21% Public Companies and
Individual Investors
ADK FAQ
What was Diagnos Inc’s price range in the past 12 months?
Diagnos Inc lowest stock price was C$0.18 and its highest was C$0.43 in the past 12 months.
What is Diagnos Inc’s market cap?
Diagnos Inc’s market cap is C$22.41M.
When is Diagnos Inc’s upcoming earnings report date?
Diagnos Inc’s upcoming earnings report date is Aug 21, 2025 which is in 34 days.
How were Diagnos Inc’s earnings last quarter?
Diagnos Inc released its earnings results on May 28, 2025. The company reported -C$0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.013.
Is Diagnos Inc overvalued?
According to Wall Street analysts Diagnos Inc’s price is currently Overvalued.
Does Diagnos Inc pay dividends?
Diagnos Inc does not currently pay dividends.
What is Diagnos Inc’s EPS estimate?
Diagnos Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diagnos Inc have?
Diagnos Inc has 101,862,976 shares outstanding.
What happened to Diagnos Inc’s price movement after its last earnings report?
Diagnos Inc reported an EPS of -C$0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.167%.
Which hedge fund is a major shareholder of Diagnos Inc?
Currently, no hedge funds are holding shares in TSE:ADK
Diagnos Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.25%
12-Months-Change
Fundamentals
Return on Equity
366.78%
Trailing 12-Months
Asset Growth
447.78%
Trailing 12-Months
Company Description
Diagnos Inc
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
Technical Analysis
Aiml Resources
―
Treatment.com International
―
Telecure Technologies Inc
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―